Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Price from Oct 29, 2026Financials updated Oct 12, 2026
Explore stock sections · swipe left or right
PHR · Price history
Price at last available close
$12.37
+$2.36 (+23.58%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2026-01-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks.
How they make money
Phreesia generates revenue primarily through subscription-based fees from healthcare services clients for its software platform and through transaction-based fees for payment processing services. Additionally, the company earns revenue from life sciences organizations that pay to deliver targeted educational content and health-related information to patients through the Phreesia platform.
Products & services
Phreesia provides an integrated software, payments, and engagement platform that supports the patient journey, including care discovery, scheduling, intake, payment processing, and post-visit follow-up via mobile devices, tablets, and kiosks.
Brands & revenue mix
Phreesia
The primary brand under which the company's integrated software, payments, and engagement platform is marketed.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
The company does not have any single customer that accounts for more than 10% of its total revenue as of the fiscal year ended January 31, 2026.
Suppliers, materials & equipment
Cloud infrastructure and hosting providers — The company relies on third-party cloud infrastructure providers to host its platform and store data; specific supplier names are unnamed.Source
Strengths
Integrated platform addressing access, affordability, and outcomesSource
Significant market reach with approximately 180 million patient visits facilitated in fiscal 2026Source
Risks
Dependence on the healthcare industry and potential changes in healthcare regulationsSource
Risks associated with data privacy, security, and potential breaches of sensitive patient informationSource
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-07-31.
Total debt increased 431.2% versus the same quarter last year.
Compare the added borrowing with available cash, cash generation and maturities. A percentage increase from a small starting balance can look large without measuring the full debt burden.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
33
Poor
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
49
Weak
Financial Strength
33
Business Quality / Moat
75
Management
52
Growth Quality
55
Risk / Durability
16
Weak Company · Expensive Stock
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
27
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
38/100
Building Historical Record
Model Score 38/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
What we like
•Asset quality scores strongly
What to watch
•Debt service risk
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak
•Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for PHR
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can PHR maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•Is PHR's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
•Does PHR's balance between cash and debt leave enough flexibility if business conditions weaken?
•What future growth or profitability would be needed to justify PHR's current valuation?
•What does the current fundamental change risk warning mean for the reliability or interpretation of PHR's score?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for PHR
Detected from reported data — verify before acting.
Debt service risk
Interest coverage is low (~-1.0x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on PHR.
Potential upside factors
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Integrated platform addressing access, affordability, and outcomes.
+Significant market reach with approximately 180 million patient visits facilitated in fiscal 2026.
+Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
−Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
−Dependence on the healthcare industry and potential changes in healthcare regulations.
−Risks associated with data privacy, security, and potential breaches of sensitive patient information.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Weak33/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Poor
38
Debt Cost6.8%
Debt Reduction YoY-475.5%
Debt / Equity0.30x
Tap for breakdown →
Revenue
Poor
29
Revenue YoY5.7%
Revenue CAGR16.1%
Net Margin2.1%
Tap for breakdown →
Asset
Strong
87
Asset Growth YoY70.9%
Liquidation/Share$6.05
Net Assets/MCap0.86x
Tap for breakdown →
Capital
Poor
14
Earnings Yield1.6%
Buyback Yield1.2%
Debt Cost6.8%
Tap for breakdown →
Management
Fair
52
ROIC-1.8%
ROE2.8%
ROA1.6%
Tap for breakdown →
Moat
Strong
75
EPS Growth—
FCF/Share Growth664.8%
Rev/Share Growth3.1%
Tap for breakdown →
Valuation
Poor
0
Intrinsic Value$6.63
Value Reference$3.98
MOS-81.8%
Tap for breakdown →
Buffett
Weak
47
Revenue29
Moat75
Valuation0
Tap for breakdown →
MOS
Poor
0
MOS %-81.8%
Value Reference$3.98
Deep Discount Reference$2.65
Tap for breakdown →
Financial
Poor
28
Interest Coverage-1.0x
ROIC-1.8%
FCF Yield10.1%
Tap for breakdown →
Master
Poor
24
Financial28
Valuation0
Debt38
Tap for breakdown →
Resilience
Weak
40
Survival Years0.3 yrs
Current Ratio1.53x
FCF Margin14.1%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
3 historical score records available
Previous Score
34
Oct 1, 2026
Change
-0.3
points
Current Score
33
Oct 12, 2026
Category Changes
Revenue-0.6
Debt0
Assets-1.9
Capital-1.0
Management0
Moat0
Valuation0
Buffett-0.4
PHR decreased 0.3 points because some fundamentals weakened.
Projected Score
Projected Score
38
Projected Change
+4.8 points
Preliminary comparable-period financial changes suggest improvement of approximately 4.8 points. This is a projected estimate, not the official WallStreetScore.
Monetary values in USD. Share counts in raw units.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2026
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
$507.8M
$480.6M
$419.8M
$356.3M
····
····
····
····
····
····
Cost of Revenue
$185.1M
$154.1M
$134.9M
$124.0M
····
····
····
····
····
····
Gross Profit
$322.7M
$326.5M
$284.9M
$232.3M
····
····
····
····
····
····
Research & Development
$116.3M
$121.5M
$117.4M
$112.3M
····
····
····
····
····
····
SG&A Expenses
$176.9M
$180.1M
$197.7M
$226.9M
····
····
····
····
····
····
Operating Expenses
$306.5M
$333.1M
$343.0M
$368.8M
····
····
····
····
····
····
EBITDA
$56.1M
$29.5M
-$25.6M
-$104.0M
····
····
····
····
····
····
Operating Income
$16.2M
-$6.6M
-$58.1M
-$136.5M
····
····
····
····
····
····
Interest Expense
$10.7M
$7.0M
$2.3M
$1.9M
····
····
····
····
····
····
Income Before Tax
$2.8M
-$8.9M
-$55.8M
-$135.3M
····
····
····
····
····
····
Income Tax Expense
-$7.7M
-$11.2M
$2.7M
$1.5M
····
····
····
····
····
····
Net Income
$10.4M
$2.3M
-$58.5M
-$136.9M
····
····
····
····
····
····
Basic EPS
$0.17
$0.04
$-1.02
$-2.51
····
····
····
····
····
····
Basic Shares
61.88M
59.74M
57.59M
54.56M
····
····
····
····
····
····
Diluted Shares
62.46M
61.49M
57.59M
54.56M
····
····
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Margins expanded
What Weakened
Cash position declined
Debt increased
Potential Score Impact
Positive indicators included revenue growth, EPS growth, net income margin. Pressure indicators included cash levels, debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 10.4%. EPS increased 189.6%. Cash declined 25.8%. Total debt increased 431.2%. Net income margin improved by 0.9 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Upgrade to Premium to unlock all earnings history.View plans
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.